| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
-Reductase1
University Departments of Surgery (C.W.B., F.K.H.), Pathology (F.D.), Medicine (K.C.), and Urology (P.B.), Western General Hospital, Edinburgh; and the Department of Urology, Glasgow Royal Infirmary (C.B.), Glasgow, Scotland
Address all correspondence and requests for reprints to: Dr. Fouad K. Habib, University Department of Surgery, Western General Hospital, Edinburgh, Scotland EH4 2XU. E-mail: fkh{at}srvo.med.ed.ac.uk
We have developed a coculture system for primary fibroblast and
epithelial cells derived from benign prostatic hyperplasia (BPH) that
retained many of the characteristics of the intact human prostate. In
contrast to separately cultured prostate fibroblast and epithelial
cells, cocultures of fibroblasts and epithelial cells maintained
messenger ribonucleic acid expression and functional activity for both
isoenzymes of 5
-reductase (type I and type II) as well as maintained
expression of androgen receptors and prostate-specific antigen.
Furthermore, levels of prostate-specific antigen secreted by cocultured
epithelial cells were increased by treatment with androgens, mimicking
the situation in the human gland. This contrasted with conventionally
cultured fibroblasts or epithelial cells, which failed to express
5
-reductase type II and rapidly lost expression of androgen
receptors and androgen sensitivity upon being placed into culture.
Electron microscopy demonstrated intracellular structures indicative of
the differentiated state of the cocultured cell types, including round
nuclei, tonofibrils, and microvilli in epithelial cells and elongated
nuclei; large amounts of Golgi and cilia; along with immature collagen
fibers in fibroblasts. The present study demonstrates that the
coculture model reflects more closely the in vivo system
for human BPH and is thus a far more suitable model for investigating
the molecular and cellular events that underlie BPH than current
in vitro systems.
This article has been cited by other articles:
![]() |
C. K M Ho, J. Nanda, K. E Chapman, and F. K Habib Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen J. Endocrinol., June 1, 2008; 197(3): 483 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Martin, M. Ross, K. E. Chapman, R. Andrew, P. Bollina, J. R. Seckl, and F. K. Habib CYP7B Generates a Selective Estrogen Receptor {beta} Agonist in Human Prostate J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2928 - 2935. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Habib, M. Ross, C. W. Bayne, P. Bollina, K. Grigor, and K. Chapman The Loss of 5{alpha}-Reductase Type I and Type II mRNA Expression in Metastatic Prostate Cancer to Bone and Lymph Node Metastasis Clin. Cancer Res., May 1, 2003; 9(5): 1815 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Lang, M. Stark, A. Collins, A. B. Paul, M. J. Stower, and N. J. Maitland Experimental Prostate Epithelial Morphogenesis in Response to Stroma and Three-Dimensional Matrigel Culture Cell Growth Differ., December 1, 2001; 12(12): 631 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gao, J. T. Arnold, and J. T. Isaacs Conversion from a Paracrine to an Autocrine Mechanism of Androgen-stimulated Growth during Malignant Transformation of Prostatic Epithelial Cells Cancer Res., July 1, 2001; 61(13): 5038 - 5044. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Asada, T. Sonoda, M. Ojiro, S. Kurata, T. Sato, T. Ezaki, and S. Takayasu 5{{alpha}}-Reductase Type 2 Is Constitutively Expressed in the Dermal Papilla and Connective Tissue Sheath of the Hair Follicle in Vivo But Not during Culture in Vitro J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2875 - 2880. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M Rocha, L A. Wickham, L. A da Silveira, K. L Krenzer, F.-S. Yu, I. Toda, B. D Sullivan, and D. A Sullivan Identification of androgen receptor protein and 5alpha -reductase mRNA in human ocular tissues Br. J. Ophthalmol., January 1, 2000; 84(1): 76 - 84. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |